Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Stress, dysregulation of drug reward pathways, and the transition to drug dependence.

Koob G, Kreek MJ.

Am J Psychiatry. 2007 Aug;164(8):1149-59. Review.

2.

Drug addiction, dysregulation of reward, and allostasis.

Koob GF, Le Moal M.

Neuropsychopharmacology. 2001 Feb;24(2):97-129. Review.

3.

Addiction as a stress surfeit disorder.

Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW Jr, George O.

Neuropharmacology. 2014 Jan;76 Pt B:370-82. doi: 10.1016/j.neuropharm.2013.05.024. Epub 2013 Jun 6. Review.

4.

Drug abuse: hedonic homeostatic dysregulation.

Koob GF, Le Moal M.

Science. 1997 Oct 3;278(5335):52-8.

PMID:
9311926
5.

Drug dependence: stress and dysregulation of brain reward pathways.

Kreek MJ, Koob GF.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):23-47. Review. No abstract available.

PMID:
9716928
6.

Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.

Koob GF.

Psychopharmacology (Berl). 2017 May;234(9-10):1315-1332. doi: 10.1007/s00213-016-4484-6. Epub 2017 Jan 3. Review.

PMID:
28050629
7.

Stress, alcohol and drug interaction: an update of human research.

Uhart M, Wand GS.

Addict Biol. 2009 Jan;14(1):43-64. doi: 10.1111/j.1369-1600.2008.00131.x. Epub 2008 Oct 9. Review.

8.

Neuroadaptive mechanisms of addiction: studies on the extended amygdala.

Koob GF.

Eur Neuropsychopharmacol. 2003 Dec;13(6):442-52. Review.

PMID:
14636960
9.

Neurobiological substrates for the dark side of compulsivity in addiction.

Koob GF.

Neuropharmacology. 2009;56 Suppl 1:18-31. doi: 10.1016/j.neuropharm.2008.07.043. Epub 2008 Aug 7. Review.

10.

Chronic stress, drug use, and vulnerability to addiction.

Sinha R.

Ann N Y Acad Sci. 2008 Oct;1141:105-30. doi: 10.1196/annals.1441.030. Review.

11.

Corticotropin releasing factor: a key role in the neurobiology of addiction.

Zorrilla EP, Logrip ML, Koob GF.

Front Neuroendocrinol. 2014 Apr;35(2):234-44. doi: 10.1016/j.yfrne.2014.01.001. Epub 2014 Jan 20. Review.

13.
14.

Addiction and the brain antireward system.

Koob GF, Le Moal M.

Annu Rev Psychol. 2008;59:29-53. Review.

PMID:
18154498
15.
16.

Neurocircuitry of alcohol addiction: synthesis from animal models.

Koob GF.

Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3. Review.

PMID:
25307567
17.

The role of CRF and CRF-related peptides in the dark side of addiction.

Koob GF.

Brain Res. 2010 Feb 16;1314:3-14. doi: 10.1016/j.brainres.2009.11.008. Epub 2009 Nov 11. Review.

18.

Review. Neurobiological mechanisms for opponent motivational processes in addiction.

Koob GF, Le Moal M.

Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3113-23. doi: 10.1098/rstb.2008.0094. Review.

19.

Drug-activation of brain reward pathways.

Wise RA.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):13-22. Review. No abstract available.

PMID:
9716927
20.

A neuroendocrine role in cocaine reinforcement.

Goeders NE.

Psychoneuroendocrinology. 1997 May;22(4):237-59. Review.

PMID:
9226728

Supplemental Content

Support Center